Sterling Investment Advisors, Ltd.

Position in REPL — Replimune Group, Inc.

CIK 1701132 BERWYN, PA

Position in REPL

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$136,161

New position

Shares Held

12,300

first reported quarter

Ownership

0.013%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#124

of 198 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Sterling Investment Advisors, Ltd. holds $2,227,448 across 4 Biotechnology names. REPL ranks #3 (6.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,947	$1,837,572
2	IMNM	Immunome Inc.	9,918	$210,162
3	REPL	Replimune Group, Inc. This page	12,300	$136,161
4	ANVS	Annovis Bio, Inc.	23,416	$43,553

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$136,161	12,300	—	Shares	Sole	2026-07-28
No filing history on record for this holder in this stock.